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Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81 A81experimental OA. This OA chondrocyte phenotype could be counter-
acted by overexpression of FLAG-Bapx1/Nkx3.2 and by BMP-7 in a
Bapx1/Nkx3.2 dependent manner. In addition, we mimicked an OA
inﬂammatory environment by exposing healthy HACs to OA synovial
ﬂuid (SF) and in agreement with its katabolic properties, SF exposure
lead to decreased Bapx1/Nkx3.2 expression and overexpression of
FLAG-Bapx1/Nkx3.2 protected the HACs against the effects of SF
exposure. Together these data show that overexpression of Bapx1/
Nkx3.2 in OA HACs and in healthy HACs exposed to an OA synovial ﬂuid
environment is able to change the OA-associated chondrocyte hyper-
trophic phenotype to a more chondrogenic phenotype and counteract
the expression of important OA related katabolic genes.
Conclusions: We show that Bapx1/Nkx3.2 is an important, yet unrec-
ognized, molecular switch that is centrally involved in controlling the
hypertrophic phenotype of the post-developmental articular chon-
drocyte. Our data suggest that due to the OA environment functional
Bapx1/Nkx3.2 levels drop in OA chondrocytes, leading to destabilization
of the Sox9-Runx2 balance and causing a phenotypic shift towards a
hypertrophic and katabolic differentiation state. Although central in the
development of OA, there is a lack of treatment options that address the
chondrocyte phenotype and important effort is needed to identify tar-
getable pathways or individual factors that alter the chondrocyte’s
phenotype in OA. We expect that Bapx1/Nkx3.2 provides an interesting
candidate to pursue such an approach.
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Purpose: Low back pain (LBP) is the most common musculoskeletal
condition affecting an individual’s ability to work and manage activ-
ities of daily living. Degenerative intervertebral disc (IVD) disease is
one of the most common causes of LBP with up to 10% of these indi-
viduals developing chronic disability. Spinal fusion for chronic dis-
cogenic LBP is invasive, has mixed long-term results, and appears to
have little value over conservative measures such as physiotherapy and
rehabilitation. There is increasing interest in cell therapy for degen-
erative IVD disease that aims to repair and regenerate the IVD.Previous studies assessing the efﬁcacy of stem cell injection into
degenerated IVDs have reported positive ﬁndings. However studies
have been predominantly limited to small animals, targeting the
nucleus pulposus (NP), with short term follow-up. The purpose of this
study was to utilize an in vivo ovine model of IVD degeneration to
determine if allogeneic mesenchymal stem cells (MSCs) delivered to
the NP or the annulus ﬁbrosus (AF) of degenerated lumbar IVDs leads
to improved indices of disc health.
Methods: Bone marrow aspirates were obtained from the iliac crest of
8-week-old sheep. MSCs were isolated and then culture expanded for 4
passages. IVD degeneration was induced by a precise postero-lateral
annulotomy at three lumbar levels in eight 2-year-old sheep. Six
months later, each degenerated IVD was randomized to one of three
treatments: Injection of MSC (1 million cells/0.2ml phosphate buffered
saline) into i) the previously incised AF (AFI) or ii) into the NP (NPI); or
iii) no injection (negative control, NC). The superior adjacent (normal)
IVD received an injection of phosphate buffered saline only (0.2ml) into
the NP (positive control, PC). Radiographs and magnetic resonance
image (MRI) scans were obtained at baseline, 6, 9, and 12 months to
determine disc height index (DHI), disc height (DH) and grade of disc
degeneration at each timepoint. Discs were harvested at 12 months for
biochemical (water, proteoglycan and hydroxyproline content) and
histological analysis (disc degeneration grade).
Results: IVD degenerationwas consistently observed at 6 months in the
24 discs that underwent postero-lateral annulotomy. This was charac-
terized by reduced DHI (33%, p<0.01), reduced DH (p<0.0001), and
increased grade of disc degeneration both on MRI scan and subsequent
histological analysis at 12 months (p<0.0001). These results were not
observed in the PC discs. Six months following stem cell injection; DHI
had recovered by 16% and 33% in the NPI and AFI groups respectively
(p<0.01); DH had recovered in the NPI and AFI groups by 18% and 22%
respectively (p<0.02); Mean Pﬁrrmann grade improved from 3.25 to
2.67 (-0.58) in the AFI group and from 2.96 to 2.43 (-0.53) in the NPI
group, whilst the NC group improved from 3.10 to 2.81 (-0.29). Mean
histopathological grade improved in both the NPI (p<0.02) and the AFI
(p<0.002) groups when compared to the NC group. No signiﬁcant dif-
ferences were noted in the glycosaminoglycan (GAG) or the hydrox-
yproline (HyPro) content across all four groups.
Conclusions: Intervertebral disc degeneration was reliably induced in
2-year-old sheep by the performance of a postero-lateral annulotomy
and allowing 6 months for the degeneration to occur. In this ovine
model, the injection of allogeneic MSCs into either the annulus ﬁbrosus
or the nucleus pulposus of degenerated IVD resulted in signiﬁcant
improvements over 6 months in disc health (DHI, DH and grade of disc
degeneration) when compared to control groups. Thus, improvements
in disc health appear to be independent of the site of stem cell injection
(annulus ﬁbrosus or nucleus pulposus). No measurable improvements
were observed in disc biochemistry. Further study into the efﬁcacy of
MSCwould appear to bewarranted for the treatment of established disc
degeneration.
